# Lotte Biologics to invest $3B to build three plants in South Korea

Lotte Biologics will invest $3 billion to build a bio industrial complex with three plants in South Korea by 2030, with annual capacity of 360,000 liters of antibody drugs. The first plant is scheduled for commercial production from 2027.

- Type: New facility
- Announced: 2023-01-11
- Where: South Korea, South Korea
- Value: $3.00B
- Starts operating: 2027
- Status: announced
- Capacity: 360,000 liters of antibody drugs per year
- Products: antibody drugs
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Lotte Biologics](https://endata.com/companies/67798.md)

## Sources

- [pulse.mk.co.kr](https://pulse.mk.co.kr/news/english/10602664), 2023-01-11: "Lotte Biologics will invest $3 billion to build a bio industrial complex that will house three plants with an annual production capacity of 360,000 liters of antibody drugs in South Korea by 2030."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.